Controlled study of ONO-5920 in patients with involutional osteoporosis in Japan
Phase of Trial: Phase III
Latest Information Update: 06 Jun 2016
At a glance
- Drugs Minodronic acid (Primary)
- Indications Fracture; Osteoporosis; Postmenopausal osteoporosis; Vertebral fracture
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Ono Pharmaceutical
- 06 Oct 2013 Results presented at the 35th Annual Meeting of the American Society for Bone and Mineral Research.
- 01 Jul 2012 Results of the 1-year extension study published in the Journal of Bone and Mineral Metabolism.
- 01 Aug 2009 Results were published in Osteoporosis International.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History